Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Sebastian

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 14, 2012
Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patientsElizabeth L Yanik, Sonia Napravnik, Christopher B Hurt, et al.
AIDS (London, England)|September 24, 2016
Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durabilityCynthia L Gay, Sarah J Willis, Anna B Cope, et al.
AIDS (London, England)|April 14, 2011
Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infectionCynthia L Gay, Ashley J Mayo, Chelu K Mfalila, et al.
AIDS (London, England)|August 11, 2020
Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infectionCynthia L Gay, Dayna T Neo, Aaron S Devanathan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Acquired Immune Deficiency Syndromes (1999)|June 14, 2012
Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patientsElizabeth L Yanik, Sonia Napravnik, Christopher B Hurt, et al.
AIDS (London, England)|September 24, 2016
Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durabilityCynthia L Gay, Sarah J Willis, Anna B Cope, et al.
AIDS (London, England)|April 14, 2011
Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infectionCynthia L Gay, Ashley J Mayo, Chelu K Mfalila, et al.
AIDS (London, England)|August 11, 2020
Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infectionCynthia L Gay, Dayna T Neo, Aaron S Devanathan, et al.
Pageof 1